Impaired progesterone signaling can be one of the mechanisms of endometriosis development; therefore, therapies directed toward correcting this progesterone inaction can be promising for endometriosis treatment and prevention.
Key Points
Lay Summary
Dr. Serin Seckin briefly discussed some of the projects that received part of the $400,000 in research grants that the EFA awarded this past year.
Key Points
Lay Summary
Dr. Marisa Weiss, the Chief Medical Officer and Founder of Breastcancer.org, provides listeners with information about Breast Cancer and possible steps that can be taken to mitigate one's risk for the disease.
Key Points
Lay Summary
High-Mobility Group Box 1 expression is found to be increased in the menstrual blood, which the authors believe drive endometriosis disease development.
Key Points
Lay Summary
A French study shows macrophage migration inhibitory factor (MIF) can be a therapeutic target for endometriosis.
Key Points
Lay Summary